Bilateral foam polidocanol sclerotherapy of great saphenous veins and their tributaries in synchronous procedure.
bilateral varicose veins
complications
foam sclerotherapy
Journal
Jornal vascular brasileiro
ISSN: 1677-7301
Titre abrégé: J Vasc Bras
Pays: Brazil
ID NLM: 101262256
Informations de publication
Date de publication:
16 Jun 2021
16 Jun 2021
Historique:
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Chronic venous insufficiency is a highly prevalent disease. Advanced cases have high morbidity. To evaluate the risks and benefits of foam sclerotherapy in patients who underwent bilateral treatment of the great saphenous veins in a single procedure, in selected cases of advanced venous insufficiency. We retrospectively reviewed 55 patients (110 limbs) with bilateral incompetence of the great saphenous veins who had undergone foam sclerotherapy treatment bilaterally, using a maximum dose of 20 ml of foam per patient and inelastic compression. In 81 (73.6%) of the 110 saphenous veins analyzed, occlusion was obtained in the first session. After a second session this figure rose to 106 (96.3%) and all 110 (100%) veins were occluded after three sessions. Bilateral occlusion of the great saphenous veins was achieved in 27 patients (50%) in one session, in 34 (62%) patients in two sessions, and in 55 (100%) patients in three sessions. At 42 days after sclerotherapy, there was complete ulcer healing in seven (63%) of the 11 patients with ulcers and partial healing in 3 (27%) of these patients. One patient (1.8%) had self-limited lipothymia and visual scotomas, 3 patients (5.45%) had skin spots, and 19 patients (34.5%) developed retained intravascular coagulum. Bilateral foam sclerotherapy in a synchronous procedure is an option to be considered for treatment of varicose veins of the lower limbs.
Sections du résumé
BACKGROUND
BACKGROUND
Chronic venous insufficiency is a highly prevalent disease. Advanced cases have high morbidity.
OBJECTIVES
OBJECTIVE
To evaluate the risks and benefits of foam sclerotherapy in patients who underwent bilateral treatment of the great saphenous veins in a single procedure, in selected cases of advanced venous insufficiency.
METHODS
METHODS
We retrospectively reviewed 55 patients (110 limbs) with bilateral incompetence of the great saphenous veins who had undergone foam sclerotherapy treatment bilaterally, using a maximum dose of 20 ml of foam per patient and inelastic compression.
RESULTS
RESULTS
In 81 (73.6%) of the 110 saphenous veins analyzed, occlusion was obtained in the first session. After a second session this figure rose to 106 (96.3%) and all 110 (100%) veins were occluded after three sessions. Bilateral occlusion of the great saphenous veins was achieved in 27 patients (50%) in one session, in 34 (62%) patients in two sessions, and in 55 (100%) patients in three sessions. At 42 days after sclerotherapy, there was complete ulcer healing in seven (63%) of the 11 patients with ulcers and partial healing in 3 (27%) of these patients. One patient (1.8%) had self-limited lipothymia and visual scotomas, 3 patients (5.45%) had skin spots, and 19 patients (34.5%) developed retained intravascular coagulum.
CONCLUSIONS
CONCLUSIONS
Bilateral foam sclerotherapy in a synchronous procedure is an option to be considered for treatment of varicose veins of the lower limbs.
Identifiants
pubmed: 34211536
doi: 10.1590/1677-5449.200178
pii: jvbAO20200178_PT-EN
pmc: PMC8218854
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e20200178Informations de copyright
Copyright© 2021 The authors.
Déclaration de conflit d'intérêts
Conflicts of interest: No conflicts of interest declared concerning the publication of this article.
Références
J Vasc Surg Venous Lymphat Disord. 2020 May;8(3):342-352
pubmed: 32113854
Phlebology. 2015 Mar;30(2):113-8
pubmed: 24335090
Eur J Vasc Endovasc Surg. 2010 Apr;39(4):500-7
pubmed: 20097585
Dermatol Surg. 2002 Jan;28(1):11-5
pubmed: 11991262
Phlebology. 2009 Jun;24(3):131-8
pubmed: 19470865
Arch Dermatol. 2003 Nov;139(11):1494-6
pubmed: 14623712
J Vasc Bras. 2017 Jul-Sep;16(3):239-243
pubmed: 29930653
Phlebology. 2014 Jul;29(6):338-54
pubmed: 23559590
J Vasc Surg. 2000 Jun;31(6):1307-12
pubmed: 10842165
Indian J Surg. 2015 Dec;77(Suppl 3):816-21
pubmed: 27011463
Radiol Bras. 2018 Nov-Dec;51(6):372-376
pubmed: 30559554
Dermatol Surg. 2014 Aug;40(8):892-8
pubmed: 25022711
Phlebology. 2016 Aug;31(7):506-13
pubmed: 26224059
AMB Rev Assoc Med Bras. 1976 Aug;22(8):296-7
pubmed: 1086493
Dermatol Surg. 2004 May;30(5):687-93; discussion 693
pubmed: 15099309
Phlebology. 2012 Feb;27(1):19-24
pubmed: 21705479
Vasc Med. 2010 Feb;15(1):27-32
pubmed: 19797263
J Int Coll Surg. 1950 Jun;13(6):765-71
pubmed: 15428675
Wideochir Inne Tech Maloinwazyjne. 2016;11(2):67-75
pubmed: 27458485
Phlebology. 2011 Oct;26(7):280-4
pubmed: 21422195
J Ayub Med Coll Abbottabad. 2019 Oct-Dec;31(Suppl 1)(4):S641-S645
pubmed: 31965766
Dermatol Surg. 2001 Jan;27(1):58-60
pubmed: 11231246
Eur J Vasc Endovasc Surg. 2009 Dec;38(6):758-63
pubmed: 19744867
J Clin Nurs. 2017 May;26(9-10):1189-1203
pubmed: 27706876